Seeking Alpha
Seeking Alpha Portfolio App for iPad
Finance
(1)
Market Currents

JNJ promoted illegal marketing of its antipsychotic drug Risperdal by paying physicians to give...

  • Tuesday, September 25, 2012, 4:26 PM ET
    JNJ promoted illegal marketing of its antipsychotic drug Risperdal by paying physicians to give favorable speeches, subsidizing golf trips and even having sales staff “butter up doctors” with bags of “Risperdal Popcorn,” according to one of its managers in court testimony today. The testimony casts a pall over the company's marketing tactics, which, in addition to the 420 suits currently filed against the company by individuals claiming to have been injured by the drug, are the subject of government probes and Medicare fraud lawsuits filed by state officials.
Track new comments on this story

This news story has 5 comments:

  •  
    New CEO needs to clean house now and not waite for next spring. At J&J a manager has no power to command any strategy, all comes from above. The other issue is that out of fear of getting fired sales teams would do anything ordered, best guess is that if it comes from the big boss, it must be ok. J&J is one of the best company worldwide, and to keep that rank, the house needs to be free of individuals not willing to live by the Credo.
    25 Sep 2012, 05:43 PM Reply Like
  •  
    As a stockholder I am very unhappy that
    this was going on. If you can't sell medication
    the right way, then do not sell it at all.
    25 Sep 2012, 07:32 PM Reply Like
  •  
    Wow, how far they've fallen. JNJ used to be the bastion of Long Term vision, Long Term shareholder value creation, and putting customers first. Now they look like a Johnny-come-lately, scrambling to pick up the pieces that other big pharma left behind.

    I'm a firm believer that they should invest more in the direction of medical equipment.
    25 Sep 2012, 10:14 PM Reply Like
  •  
    420 law-suits filed. How many outside those 420 possibly got some help. Of the 420, how many were convinced by an ambulance chaser ? I don't think that I should make excuses for a behemoth like JNJ. But early this AM I read about trials that are being started for a drug from the 50's, Metformin. This product used for diabetes has been effective for so long, & now there is a possibility that it can offer help in many types of cancer,starting with breast cancer & possibly many other types. In this room, we shouldn't look at the down side,but on the idea that it may have helped thousands or even millions of people world wide.
    Those 420 will now spend possibly years in litigation & when it's all settled it will mean a bundle for the law firms, but the alleged victim will get a token check.
    26 Sep 2012, 06:08 AM Reply Like
  •  
    It's a shame that lawsuits are part of business - - If they are frivilous that is one thing - - If valid then the company needs to do some deep soul searching and clean up its act - A bad reputation is caused by the leadership and it can kill a company, even one as big as JNJ (Think Enron)
    26 Sep 2012, 03:35 PM Reply Like
LATEST|
TODAY SO FAR|
YESTERDAY
Other date
DJIA (DIA) S&P 500 (SPY)

HEALTHCARE ETFs IN FOCUS

Latest Healthcare Articles
More Latest Articles »